Tesamorelin (5 mg Vial)

This reference covers Tesamorelin (5 mg Vial) in vial format: reconstitution steps, the concentration each volume produces, syringe-unit conversions and storage conditions for the lyophilized and reconstituted material.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Tesamorelin (5 mg Vial)

Synonyms/Alias: Tesamorelin

Purity: Specification by inquiry

Custom Peptide Support

  • Sequence, purity and scale confirmation
  • CoA and technical documentation requests
  • API, research and cosmetic peptide options
  • Distributor and institution quotation support

This reference covers Tesamorelin (5 mg Vial) in vial format: reconstitution steps, the concentration each volume produces, syringe-unit conversions and storage conditions for the lyophilized and reconstituted material.

Quickstart

Reconstitute: Add 2.5 mL bacteriostatic water per 5 mg vial β†’ 2.0 mg/mL concentration.

Standard daily dose: 2 mg (2000 mcg) once daily subcutaneously (FDA-approved protocol).

Easy measuring: At 2.0 mg/mL, 1 unit = 0.01 mL = 20 mcg on a U-100 insulin syringe.

Storage: Lyophilized: refrigerate at 2–8 Β°C (35.6–46.4 Β°F); reconstituted: refrigerate and use within 7 days with bacteriostatic water.

Notes

Practical considerations for consistency and safety. Use new sterile insulin syringes for each injection; dispose in a sharps container [10]. Rotate injection sites (abdomen at least 2 inches from navel, thighs, upper arms) to reduce local irritation [6] [10]. Inject slowly; wait a few seconds before withdrawing the needle. Monitor IGF-1 levels periodically due to potent GH stimulation; observe blood glucose in diabetic patients [9]. Document daily dose and site rotation to maintain consistency.

Single peptide protocol reference: Available for related research, development or formulation inquiry workflows.

Reconstitution and handling reference: Available for related research, development or formulation inquiry workflows.

Research-use documentation inquiry: Available for related research, development or formulation inquiry workflows.

Week 1
Daily Dose (mg / mcg): 1 mg / 1000 mcg | Units (per injection) (mL): 50 units (0.50 mL)
Weeks 2–12+
Daily Dose (mg / mcg): 2 mg / 2000 mcg | Units (per injection) (mL): 100 units (1.00 mL)
Long-term Storage Conditions
Lyophilized: refrigerate at 2–8 Β°C (35.6–46.4 Β°F); reconstituted: refrigerate and use within 7 days with bacteriostatic water.
Shipping Condition
Shipping conditions by inquiry

Peptide Vials (Tesamorelin, 5 mg each): 8 weeks β‰ˆ 23 vials (112 mg total)

12 weeks β‰ˆ 34 vials (168 mg total)

16 weeks β‰ˆ 45 vials (224 mg total)

Insulin Syringes (U-100, 1 mL capacity): Per week: 7 syringes (1/day)

8 weeks: 56 syringes

12 weeks: 84 syringes

16 weeks: 112 syringes

Bacteriostatic Water (10 mL bottles): Use 2.5 mL per vial for reconstitution. 8 weeks (23 vials): 57.5 mL β†’ 6 Γ— 10 mL bottles

12 weeks (34 vials): 85 mL β†’ 9 Γ— 10 mL bottles

16 weeks (45 vials): 112.5 mL β†’ 12 Γ— 10 mL bottles

Alcohol Swabs: One for the vial stopper + one for the injection site each day. Per week: 14 swabs (2/day)

8 weeks: 112 swabs β†’ recommend 2 Γ— 100-count boxes

12 weeks: 168 swabs β†’ recommend 2 Γ— 100-count boxes

16 weeks: 224 swabs β†’ recommend 3 Γ— 100-count boxes

Product Gallery

Quick Inquiry

Customer Support & Price Inquiry

Send product, purity, quantity, destination and documentation requirements. Quantai will follow up through WhatsApp or email.

Email: kongq687@gmail.com

WhatsAppMia WhatsApp Business QR code

Address: Huangpu District, Guangzhou, China